|  %20%20%20%20%20%20 |
|
| Heart Rhythm Data Excites, Fintech Momentum Builds, and Earnings Misses Hammer Cyclicals |
|
| New clinical data in heart rhythm treatment generated strong interest, while solid results in the fintech space added further momentum. At the same time, weaker-than-expected earnings reports weighed on several cyclical names. |
|
| | The Fuel Shift (Sponsored) | | | A major energy breakthrough is unfolding — and it's happening faster than most realize. | An MIT-trained scientist has unlocked a virtually inexhaustible energy source, now drawing attention from the Trump administration. | According to the U.S. Department of Energy, it could power the world for billions of years. | That's why big techs are racing to get involved. | Once operational, the fuel itself costs nothing. | Which is why early positioning — even small — could matter more than people expect. | See the full details here. |
|
| | Markets | U.S. stocks made a U-turn and ended the week higher as investors engaged in dip-buying after an earlier tech selloff. The calmer sentiment and attractive valuations were drawing buyers back into the market amid a lack of major new negative catalysts. The Dow Jones crossed 50,000 points for the first time ever. | DJIA [+2.47%] S&P 500 [+1.97%]
|
| Nasdaq [+2.18%] Russell 2k [+3.65%]
|
|
|
|
| | Market-Moving News | Investment Banking | This Is Goldman Redesigning the Bank From the Inside | | Goldman Sachs (NYSE: GS) is embedding AI deep inside its operations, targeting accounting, compliance, reconciliation, and client onboarding. | With engineers from Anthropic working alongside its teams, Goldman is building autonomous systems for workflows most banks treat as untouchable. | This is not front office flash. These are rules-heavy, judgment-driven processes that sit at the core of risk management and regulatory trust. | Scale Without the Stress | Rather than using AI for blunt cost-cutting, Goldman is using it to compress time and increase throughput. | Faster onboarding, quicker reconciliations, and fewer bottlenecks as volumes grow. | If you are watching how large banks prepare for the next decade, this is about scalability and resilience, not short-term savings. | Raising the Bar Quietly | Automating complex banking functions strengthens Goldman's execution edge while reducing reliance on fragmented systems and external vendors. | It also forces peers to rethink how much manual work they can afford to keep. | Thinking long term, the risk is obvious. AI in regulated environments must be accurate, explainable, and auditable. | Goldman's decision to build in-house signals it wants control, not shortcuts. | If this effort works, you are not just seeing AI adoption, you are watching the plumbing of modern banking get rebuilt in real time. |
|
| | Power Infrastructure | This $3.5 Billion Deal Shows Where TPG Sees Real Scarcity | | TPG (NYSE: TPG) has agreed to acquire a majority stake in Sabre Industries, valuing the company at roughly $3.5 billion. | Sabre builds critical components for electricity transmission and communications networks, the physical layer on which everything digital ultimately depends. | By taking control rather than a minority position, TPG is signaling that grid stress is structural, not cyclical. | AI Still Needs Wires | Data centers, cloud expansion, electrification, and AI workloads all collide with the same bottleneck: power delivery. | Sabre's products scale with population growth and rising power intensity, regardless of which software or model wins. | This reflects a deliberate bet on staying power rather than excitement. | When you step back and map where durable demand actually lives, TPG points to constraint-driven assets over trend-driven ones. | That kind of positioning tends to age better across cycles. | Built for Patience | Power infrastructure carries high barriers to entry. It is capital-intensive, regulated, slow to replicate, and increasingly constrained. | Those traits reward long-term ownership and operational discipline, not quick financial engineering. | This deal reinforces a focus on essential services with staying power. Execution will matter, returns come over years, not quarters. But that is the trade TPG appears comfortable making. | If this strategy continues, you are looking at a firm positioning itself as an owner of the systems that enable the next decade of growth, not the shiny layer on top, but the foundation everything else relies on. |
|
| | | | | Capital Strategy | Why Anebulo Is Choosing Runway Over Visibility | | Anebulo Pharmaceuticals (NASDAQ: ANEB) has announced plans to delist from Nasdaq and suspend SEC reporting voluntarily. | The decision is not tied to listing issues, but to a reassessment of whether public company costs still make sense at its current stage. | For a clinical-stage biotech, audits, filings, and compliance can drain capital that would otherwise fund trials. | If you are watching capital discipline, this is about extending runway, not retreating. | Freedom From the Quarter | Operating privately gives management flexibility. | Without quarterly pressure, Anebulo can focus on advancing its lead program targeting acute cannabis induced toxic effects, an area with unmet medical need and uncertain timelines. | For you, thinking strategically, this removes short-term optics and allows room for trial adjustments, regulatory navigation, or partner discussions without constant disclosure. | Tradeoffs Still Exist | Leaving public markets reduces transparency and liquidity, which can complicate fundraising. | Anebulo may lean more heavily on private capital, partnerships, licensing, or acquisition interest to move forward. | That said, private status can simplify negotiations and reduce market noise. If progress slows, the lower cost base still buys time. | Ultimately, you are looking at a reset built around execution, not headlines, with value creation pushed back into the lab rather than the ticker tape. |
|
| | Want to make sure you never miss our post-market roundup? | Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone right after the closing bell rings.
Email's great. Texts are faster. | 👉 Click here to get our closing report to your cell for free! |
|
| | Top Winners and Losers | | | Pulse Biosciences, Inc [PLSE] $20.77 (+51.72%) | Pulse Biosciences surged after reporting strong clinical results showing high success rates and a favorable safety profile for its novel atrial fibrillation ablation technology. | Rail Vision Ltd [RVSN] $5.82 (+38.91%) | Rail Vision climbed after advancing its collaboration with Israel Railways into a pilot program to evaluate its AI-powered rail yard safety system. | Bill Holdings Inc [BILL] $48.93 (+37.12%) | BILL gained after reporting quarterly earnings and revenue that topped expectations, supported by strong growth in payment volumes and customer adoption. |
| |
|
| | | | | | GrafTech International Ltd [EAF] $8.47 (-45.98%) | GrafTech fell after reporting a much wider-than-expected quarterly loss and revenue that missed forecasts by a wide margin. | Amtech Systems Inc [ASYS] $11.12 (-29.93%) | Amtech dropped after posting earnings that came in well below expectations, overshadowing revenue that was roughly in line with forecasts. | Molina Healthcare Inc [MOH] $131.71 (-25.52%) | Molina fell after reporting a surprise quarterly loss and issuing weak forward guidance amid rising medical costs and declining membership. |
| |
| | |
| | Trivia: What is the term for selling borrowed stock hoping to buy it back lower? | | | Advance Learn Profit (Sponsored) | | | The last time AI made a leap this big, one stock in our list ran 180% in 14 months.
Another doubled in less than a year. Now, the setups are back - and stronger. | One chipmaker just announced quarterly revenue growth of 88%. A cloud automation firm doubled its AI client base in July. A robotics innovator signed three new enterprise deals in Q3 alone.
| Chips, cloud, automation, robotics - all the AI companies you need in your pocket are here.
Get the 10 tickers and catalysts - free in this report.
(By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.) |
|
| | | | That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback! | Thanks for reading. I'll see you at the next open! | Best Regards,
— Adam G.
Elite Trade Club |
|
| | | | Click here to get our daily newsletter straight to your cell for free. | P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. |
| |
|
|
|
0 التعليقات:
إرسال تعليق